FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
This Quarter Return
+14.65%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$262M
AUM Growth
+$262M
(+15%)
Cap. Flow
+$9M
Cap. Flow
% of AUM
3.44%
Top 10 Holdings %
Top 10 Hldgs %
48.69%
Holding
59
New
5
Increased
14
Reduced
24
Closed
7
Top Buys
| 1 |
XENT
Intersect ENT, Inc
XENT
|
$11.4M |
| 2 |
AKRX
Akorn, Inc.
AKRX
|
$5.8M |
| 3 |
Heron Therapeutics
HRTX
|
$5.46M |
| 4 |
Omnicell
OMCL
|
$5.44M |
| 5 |
Halozyme
HALO
|
$5.37M |
Top Sells
| 1 |
LHCG
LHC Group LLC
LHCG
|
$5.06M |
| 2 |
ARRY
Array Biopharma Inc
ARRY
|
$3.88M |
| 3 |
PETX
Aratana Therapeutics, Inc.
PETX
|
$2.95M |
| 4 |
DOC
PHYSICIANS REALTY TRUST
DOC
|
$2.9M |
| 5 |
LeMaitre Vascular
LMAT
|
$2.8M |
Sector Composition
| 1 | Healthcare | 73.96% |
| 2 | Energy | 2.6% |
| 3 | Communication Services | 1.68% |
| 4 | Real Estate | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NXTM
26
DELISTED
NxStage Medical Inc.
NXTM
| $4.56M | 1.74% |
170,007
-77,008
| -31% | -$2.07M |
|
|
BLUE
27
DELISTED
bluebird bio
BLUE
| $4.48M | 1.71% |
49,270
-21,976
| -31% | -$2M |
|
|
MODN
28
DELISTED
MODEL N, INC.
MODN
| $4.4M | 1.68% |
420,750
+38,106
| +10% | +$398K |
|
29
Bio-Techne
TECH
$8.3B
| $3.88M | 1.48% |
38,202
-300
| -0.8% | -$30.5K |
|
30
BioMarin Pharmaceuticals
BMRN
$11.3B
| $2.77M | 1.06% |
31,592
-167
| -0.5% | -$14.7K |
|
31
Vertex Pharmaceuticals
VRTX
$102B
| $2.53M | 0.97% |
23,125
-100
| -0.4% | -$10.9K |
|
|
NSTG
32
DELISTED
NanoString Technologies, Inc.
NSTG
| $2.28M | 0.87% |
114,755
-1,021
| -0.9% | -$20.3K |
|
33
iShares Biotechnology ETF
IBB
$5.68B
| $2.08M | 0.79% |
7,097
-800
| -10% | -$235K |
|
34
Ionis Pharmaceuticals
IONS
$9.64B
| $2.02M | 0.77% |
50,189
+731
| +1% | +$29.4K |
|
35
Alkermes
ALKS
$4.95B
| $1.74M | 0.66% |
29,689
-30,844
| -51% | -$1.8M |
|
|
CELG
36
DELISTED
Celgene Corp
CELG
| $1.71M | 0.65% |
13,701
-96
| -0.7% | -$11.9K |
|
37
QuidelOrtho
QDEL
$1.87B
| $1.68M | 0.64% |
74,383
-897
| -1% | -$20.3K |
|
|
STRM
38
DELISTED
Streamline Health Solutions
STRM
| $1.67M | 0.64% |
1,635,945
+9,970
| +0.6% | +$10.2K |
|
|
XLVS
39
DELISTED
POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO
XLVS
| $1.38M | 0.53% |
17,285
| – | – |
|
40
Health Care Select Sector SPDR Fund
XLV
$33.8B
| $1.36M | 0.52% |
18,241
| – | – |
|
|
TEAR
41
DELISTED
TearLab Corporation
TEAR
| $1.2M | 0.46% |
421,025
-2,939,663
| -87% | +$241K |
|
42
iShares US Medical Devices ETF
IHI
$4.27B
| $1.15M | 0.44% |
7,580
| – | – |
|
43
MacroGenics
MGNX
$121M
| $1.14M | 0.44% |
61,503
-332
| -0.5% | -$6.18K |
|
|
44
LeMaitre Vascular
LMAT
$2.14B
| $1.14M | 0.43% |
46,203
-113,740
| -71% | -$2.8M |
|
45
SPDR S&P Biotech ETF
XBI
$5.29B
| $659K | 0.25% |
9,499
-2,537
| -21% | -$176K |
|
46
Sanofi
SNY
$122B
| $304K | 0.12% |
6,720
| – | – |
|
|
CEMI
47
DELISTED
Chembio diagnostics, Inc.
CEMI
| $294K | 0.11% |
55,452
-20,850
| -27% | -$111K |
|
48
Pfizer
PFE
$141B
| $293K | 0.11% |
8,558
| – | – |
|
49
Merck
MRK
$210B
| $273K | 0.1% |
4,294
| – | – |
|
50
Johnson & Johnson
JNJ
$429B
| $272K | 0.1% |
2,183
| – | – |
|